Page 85 - Looking Statement News Today

AurCrest Gold Inc.: AurCrest Gold Grants Stock Options Company" or " AurCrest") (TSXV:AGO) wishes to announce that it has issued 1,950,000 options to the a director and four geological consultants. The options are exercisable at a price of $0.24 for a period of five years. AurCrest Gold is a leader in the First Nations advancement into shared participation and inclusion in the regional mining opportunities and counts as its board of directors and management, past and present, many indigenous b...

Merck Completes Acquisition of Pandion Therapeutics Merck known as MSD outside the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Pandion Therapeutics, Inc. at a purchase price of $60 per share. As of the tender offer expiration, 27,770,123 shares of common stock of Pandion were validly tendered and not withdrawn from the tender offer, … Merck (NYSE: MRK), known as MSD ou...

Press release content from Business Wire. The AP news staff was not involved in its creation. Mike Nally to Leave Merck; Frank Clyburn to Lead All Merck Human Health March 17, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Mar 17, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Michael T. Nally, chief marketing officer, Human Health, will leave the company at the end of March, and Frank Clyburn, chief commercial officer, Human Health, will become p...

TechnipFMC plc: TechnipFMC Enters Partnership with Magnora to Develop Floating Offshore Wind Projects TechnipFMC (NYSE:FTI) (PARIS:FTI) today announced it has entered into an agreement with Magnora ASA (Magnora) to jointly pursue floating offshore wind project development opportunities under the name Magnora Offshore Wind. Magnora holds a strategic position within the renewable energy sector as an owner in offshore wind, onshore wind, and solar development projects and is a key enabler in solar...

Merck Receives Priority Review From FDA for New Drug Application for HIF-2? Inhibitor Belzutifan Application Based on Objective Response Rate From Phase 2 Trial Evaluating Belzutifan in Patients With Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma New Filing Further Strengthens Merck’s Expanding and Diverse Oncology Portfolio Merck known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted and granted priority review fo...

About ADMQ:  Since 2010, our wholly owned subsidiary, Just Right Products, Inc., has been consistently profitable, with sales topping $5.1 million in 2020. The Company sells “Anything With A Logo” on its website, JustRightProducts.com, developing products ranging from unique business cards to coffee cups, T-shirts to boots, with tens of thousands of other unique products from which to select. The Company operates a diverse vertical integrated business in the Dallas/Fort Worth area, consist...

Press release content from Business Wire. The AP news staff was not involved in its creation. Merck Receives Priority Review From FDA for New Drug Application for HIF-2α Inhibitor Belzutifan (MK-6482) March 16, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Mar 16, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a New Drug Application (NDA) for the hypoxia-ind...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Published: Mar 12, 2021 Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston Facility GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated man...

Labrador Iron Mines Holdings Limited: Labrador Iron Mines Announces Results of Preliminary Economic Assessment of the Houston Project " with low re-start capital and robust economics" Toronto, Ontario--(Newsfile Corp. - March 9, 2021) - Labrador Iron Mines Holdings Limited (OTC: LBRMF) ("LIMH" or the "Company") announces the results of an independent Preliminary Economic Assessment ("PEA") on its Houston Project prepared by Roscoe Postle Associates Inc ("RPA"), now part of SLR Consulting Ltd. ...